Device Trial Radar · NCT05958095
Curio Digital Therapy for the Treatment of Post-partum Depression
Last checked: Nov 19, 2026Latest source record: Jul 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
142
Actual
Start
Apr 1, 2023
Primary completion
May 24, 2023
Study completion Aug 15, 2023
Sponsor
- Lead sponsor
- Healthcare Innovation Technology LabNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Curio Digital Therapeutics, Inc.
- First posted
- Jul 24, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Primary Objective: Evaluate the clinical effectiveness of the MamaLift Plus app compared to control (digital sham plus treatment as usual) for the management of PPD in the observed population for a period of 9 calendar weeks. It is hypothesized that women who use the MamaLift Plus APP will experience less severe symptoms of depression in post-partum period than comparable women who do not and receive their usual care from health providers.
Conditions
- PostPartum Depression
Interventions
MamaLift PlusDevice
MamaLift Plus is a digital therapeutic designed to augment usual care and support the treatment of mild-to-moderate postpartum depression (PPD). This mobile-based intervention is grounded on principles of Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT) and includes key content areas for the treatment management of PPD. It also includes recent developments in acceptance and commitment-based therapies, specifically for the perinatal context.
Digital Sham AppDevice
The digital sham app delivers content, tips, and suggestion for general wellbeing support.
Primary outcomes
What the sponsor says the trial is designed to measure.
- EPDS ScoreTime frame: 9 week period
- EPDS Score improvementTime frame: 9 week period
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Healthcare Innovation and Technology Lab
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.